The in vitro diagnostics (IVD) market attracts considerable interest. There are hundreds of participating companies, competing in multiple areas of testing. Each IVD segment could be said to function as an industry in and of itself. There are companies who specialize in one area and companies who participate across segments. There are myriad products, from routine blood tests to complicated molecular assays and new sequencing based technologies. It's often necessary for competitors to know about all of the segments of testing as different technologies can often compete. This single volume Kalorama Information report has been written and updated for over a decade in nine editions, with the purpose of keeping readers informed about developments in clinical testing. It covers the entirety of the clinical testing market, reports on hundreds of competitors, details deals and acquisitions and computes market size statistics for important segments. Published every two years, this volume includes recent market size and forecasts to 2018 for the most important aspects of all of the major segments of clinical lab testing, including
No other report provides an similar sense of the world diagnostics market. Shara Rosen (MBA, RT) has edited nine editions of this superior work intended to provide IVD market coverage in a world perspective. A month's long research effort creates authoritative market estimates and forecasted growth models for in vitro diagnostic (IVD) testing products throughout the world.
This is a global report. The following IVD markets are included:
Not Just "Who Did What?" This Report Answers "What are the Reasons Behind the Results"
The report does just report on deals, events in the industry, laboratory trends and corporate results. It provides that information, but it also analyzes why trends are occurring, and what readers can expect in the future.
The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an IVD industry veteran, who has tracked hundreds of companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the industry as it is in 2014. The report includes data in a sizeable number of IVD segments and detailed discussion of the trends that are impacting the industry. The report also provides a realistic forecast five years into the future for companies already participating in or considering entry into this growing industry. Many top IVD companies have purchase this volume and use the data within for their business planning efforts.
The same business intelligence top companies possess is available to purchasers of this unique report.
The report contains detailed profiles of the top players in IVD. Profiling in this report describes the developments in each significant division of their business. A number of secondary players are also extensively profiled, as well as specialty companies with expertise in one testing area.
And hundreds of other companies...
All market data are based on factory sales to the end user and not retail pricing or reimbursement payments. Data for the in vitro diagnostic market are presented in U.S. dollar market size for categories of tests, and for specific analytes where possible. The dollar value of a market segment is directly proportional to the number of tests performed, because the cost of the instrumentation is generally buried in the per test price.
The information presented in this report is derived on publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author's industry knowledge combined with literature searches and interviews with industry professionals and experts in the IVD industry.
Related Reports:World In Vitro Diagnostics (IVD) Market Bundle: Molecular Diagnostics (Microbiology, Oncology, Blood, Prenatal, Inherited, Others), Cancer Diagnostics (HPV, ISH, Cytometry, PSA, FOB, Others), Infectious Diseases (ID/AST, POC, HAIs, STDs, Other)
Nov 23, 2015 - KLI5757702 - $9,000.00
The World Market for Cancer Therapeutics by Product (Monoclonal Antibodies, Tyrosine Kinase, Inhibitors, Cancer Vaccines, Cytokines, Gene Therapy, Traditional Chemotherapy), by Cancer Type (Lung, Breast, Prostate, Stomach, Liver, Cervical, Bladder, Lympho
Nov 12, 2015 - KLI5752001 - $4,200.00
QIAGEN: Company Profile
Nov 9, 2015 - KLI5734031 - $250.00
Roche Diagnostics: Company Profile
Nov 2, 2015 - KLI5726986 - $250.00
The World Market for Infectious Disease Diagnostic Tests
Nov 1, 2015 - KLI5721838 - $4,500.00
The World Market for Liquid Chromatography in Healthcare
Nov 1, 2015 - KLI5733398 - $4,500.00
Mergers and Acquisitions in the IVD Market
Oct 26, 2015 - KLI5722029 - $750.00
5 Cutting-Edge Trends in Molecular Diagnostics: White Paper
Oct 26, 2015 - KLI5721150 - $0.00
Clinical Laboratory Services Market
Oct 1, 2015 - KLI5691758 - $4,200.00
The World Market for Molecular Diagnostics, 6th Edition (Microbiology, Oncology, Blood Screening and Typing, Prenatal, Inherited Diseases, Coagulation, Organ Transplant, PCR, Sequencing, cfDNA, CTC, in situ hybridization, Others)
Sep 30, 2015 - KLI5695907 - $4,500.00
Questions?Contact a research specialist >
Live Chat Software
Most Popular ResearchThe Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition The United States Market for In Vitro Diagnostic Tests The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations) IVD Procedure Volumes and Pricing Analysis Retail Clinics Market Overview and 2014 Survey Results The Market and Potential for Molecular Point of Care Diagnostics